Welcome to the 3rd Annual Neuroimmunology Drug Development Summit:
Translate Key Technological & Mechanistic Neuroimmunology Advances into the Clinic
Translate Your Research Into the Clinic
The 3rd Neuroimmunology Drug Development Summit is the industry’s definitive and unrivalled forum focused solely on pushing the frontiers of targeting neuroinflammation for CNS Indications.
As diverse programs are advancing towards the clinic, there is a dire need to tackle the many translational challenges neuro-immunologists are facing to develop clinically effective neuroimmunology-targeted therapeutics.
Building on the success of last year’s meeting, this year’s program will uncover how leading companies in this emerging field are discovering immune-modulating targets and deploying immuno-neurology across clinical case studies.
Discuss the Translation of Therapeutic Efficacy in Neuroinflammation
As we gather the best minds in this infant field, we will put a spotlight on the latest key learnings across microglia, astrocytes, STING, TREM2 and more to help pave the way to translating key technological and mechanistic insights towards the clinic.
We will discuss the translation of therapeutic efficacy in neuroinflammation and the importance of identifying the best biomarkers and relevant models to ensure clinical trial success.
Network and Forge Collaborations Within the Industry
Join this intimate, industry led forum to not only learn from those pioneering the field, but to network and build meaningful partnerships with over 80 neuroimmunology drug development experts.
Connect with your peers from the likes of Merck, Sanofi, Biogen, Alector, Denali, Roche, Janssen, Genentech and Lundbeck to establish new relationships within this niche community.
To find out more and view the full speaker line-up, download the 2021 event guide by following the link below.
World-Class Speakers Include:
Rebecca Coll
Principal Investigator, Lecturer in Immunobiology, Wellcome-Wolfson Institute for Experimental Medicine
Queen's University Belfast, UK
Reviews From the Neuroimmunology Community:
 |
“Teriffic meeting and glad to have it on my radar” - Brett Adams, Vice President, Magnolia Neurosciences | |
| t | ||
 |
"Very focused meeting, that accomplished a lot in two days. The presentations were high quality and organised into interesting sessions" - Sally Ishizaka, Senior Director, Eisai | |
| t | ||
 |
'Excellent meeting! I learned a lot' - Gayathri Ramaswamy, Associate Director, Biogen |
Other Events in the World CNS Series:
